Diamond Member Pelican Press 0 Posted October 24, 2025 Diamond Member Share Posted October 24, 2025 New Delhi: Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic medication for seizures. The company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine extended-release tablets (USP 200 mg, 250 mg, and 300 mg), the drug firm said in a regulatory filing. This is the hidden content, please Sign In or Sign Up This is the hidden content, please Sign In or Sign Up 0 Quote Link to comment https://hopzone.eu/forums/topic/285098-alembic-pharma-gets-usfda-nod-for-generic-medication-ethealthworld/ Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.